News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Allergan Inc. (AGN) Renews Fight, Reiterates Belief That Valeant Pharmaceuticals International (VRX)'s Business Model Is Unsustainable


7/14/2014 8:31:58 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Allergan (NYSE:AGN) went on the offensive again today in its battle against a hostile takeover bid by Valeant Pharmaceuticals and its hedge fund partner, Pershing Square Capital Management, demanding more transparency from Valeant about its business and prospects for growth – even as Valeant today filed a pre-merger notification with the U.S. Federal Trade Commission.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice
Read at Wall Street Journal
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES